CellaVision AB (publ) (LON:0MR5)
150.20
-0.60 (-0.40%)
At close: Dec 17, 2025
CellaVision AB Revenue
CellaVision AB had revenue of 175.63M SEK in the quarter ending September 30, 2025, a decrease of -1.69%. This brings the company's revenue in the last twelve months to 748.45M, up 1.53% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22M with 6.78% growth.
Revenue (ttm)
748.45M SEK
Revenue Growth
+1.53%
P/S Ratio
5.01
Revenue / Employee
3.42M SEK
Employees
219
Market Cap
296.10M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |